The international market for Active Pharmaceutical Ingredient (API) manufacturers is a intricate landscape, encompassing numerous regions . PRC currently dominates the manufacturing of APIs, second to India, which is a key player in both off-patent API provision . European businesses, particularly in countries like Germany, Switzerland, and Italy,